Compound E511-2814

CAS No. 891952-39-9

Compound E511-2814( —— )

Catalog No. M32913 CAS No. 891952-39-9

Compound E511-2814 is a useful organic compound for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 3032 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Compound E511-2814
  • Note
    Research use only, not for human use.
  • Brief Description
    Compound E511-2814 is a useful organic compound for research related to life sciences.
  • Description
    Compound E511-2814 is a useful organic compound for research related to life sciences. The catalog number is T112207 and the CAS number is 891952-39-9.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    891952-39-9
  • Formula Weight
    348.42
  • Molecular Formula
    C16H20N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCC=1C=NC=CC1)C2=CC(=CN2)S(=O)(=O)N3CCCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Gypenoside LXXV

    Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect.

  • Eicosane

    Eicosane is a natural product from Sargassum fusiforme.

  • Jagged-1 (188-204) T...

    Jagged-1 (188-204) TFA is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-alphaB activation.